AIkido Pharma Revenue and Competitors

Location

$143.9M

Total Funding

Estimated Revenue & Valuation

  • AIkido Pharma's estimated annual revenue is currently $1.7M per year.(i)
  • AIkido Pharma's estimated revenue per employee is $141,667
  • AIkido Pharma's total funding is $143.9M.

Employee Data

  • AIkido Pharma has 12 Employees.(i)
  • AIkido Pharma grew their employee count by 9% last year.

AIkido Pharma's People

NameTitleEmail/Phone
1
VP Drug Development and General CounselReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$22.6M142-18%N/AN/A
#2
$41.3M25944%N/AN/A
#3
$808.8M39849%N/AN/A
#4
$1320M19018%$445MN/A
#5
$513.8M247811%$215MN/A
#6
$16.7M1154%N/AN/A
#7
$469.4M22648%$298.8MN/A
#8
$84.3M46533%N/AN/A
#9
$19.4M127-2%$46.6MN/A
#10
$81.2M44825%N/AN/A
Add Company

What Is AIkido Pharma?

SPHERIX was launched more than 35 years ago as a technology company and became a public company shortly after under the name Biospherics. Through the years the company has maintained a strong technology focus with an eye on innovation. Our technical achievements have reached as far as the surface of Mars, with experiments to search for life. And as close to home as technologies to cleanse our drinking water and search for biohazards in our air. SPHERIX entered the new millennium with continued strength and stability, with record growth and exciting opportunities, for its clients, its investors, and its employees. We are traded on NASDAQ as ticker symbol: SPEX.

keywords:N/A

$143.9M

Total Funding

12

Number of Employees

$1.7M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

AIkido Pharma News

2022-04-13 - Zacks Investment Research Downgrades AIkido Pharma ...

Get AIkido Pharma alerts: AIKI traded down $0.01 during midday trading on Monday, hitting $0.38. 56,360 shares of the company traded hands,...

2022-04-06 - AIkido Pharma Announces Strategic Investment in MasterClass

Masterclass Provides Members Access to Pre- Recorded Lectures by Top Experts. NEW YORK, April 5, 2022 /PRNewswire/ -- AIkido Pharma Inc.

2022-03-22 - Where Does Wall Street Think Aikido Pharma Inc (AIKI) Stock Will Go?

Analysts who follow Aikido Pharma Inc (AIKI) on average expect it to add 325.53% over the next twelve months. Those same analysts give the...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1M12-83%N/A
#2
$1.5M12-29%N/A
#3
$35M12-61%N/A
#4
$0.6M12-8%$5.2M
#5
$1.6M12-14%N/A